MetaboGen and BioGaia open pilot plant for new bacterial strains
BioGaia is developing probiotic products and expanding its product portfolio with new bacterial strains, developed together with the wholly-owned subsidiary MetaboGen. To take new strains through clinical development and towards eventual launch, the two companies are now opening a pilot plant in Eslöv for fermentation.The development of next-generation probiotic products often requires special conditions and new technical solutions. To meet these requirements, BioGaia and the subsidiary MetaboGen have built a pilot plant in Eslöv. The facility handles manufacturing of bacteria with